The Trend of Scientific Productions on the Use of Herbal Medicines in Metabolic Disorders in the Middle East Countries

AuthorOzra Tabatabaei-Malazyen
AuthorShekoufeh Nikfaren
AuthorMohammad Abdollahien
AuthorBagher Larijanien
OrcidOzra Tabatabaei-Malazy [0000-0003-0188-9721]en
OrcidShekoufeh Nikfar [0000-0002-5206-6197]en
OrcidMohammad Abdollahi [0000-0003-0123-1209]en
OrcidBagher Larijani [0000-0001-5386-7597]en
Issued Date2021-08-31en
AbstractContext: Prevalence of metabolic disorders, type 2 diabetes mellitus (T2DM), dyslipidemia, obesity, metabolic syndrome (MetS), and osteoporosis has been increased. Herbal medicine is an accessible, safe, and low-cost option in managing and caring for metabolic disorders. We conducted a bibliometric analysis of global scientific productions in herbal medications and metabolic disorders in the Middle East countries. Study Selection: Our search terms were “diabetes”, “dyslipidemia”, “obesity”, “osteoporosis”, “metabolic syndrome”, “herb”, and “herbal medicine” in Middle East countries through the Scopus database until January 2020. We analyzed the data regarding publication year, main journal, geographical distribution, document type, subject area, co-authorship network, the h-index of citations by Scopus analysis tools, Visualizing Scientific Landscapes (VOSviewer) version 1.6.4, and SPSS version 15. Results: Among 6408 global publications, most of the papers (> 85%) were original articles, and mostly (44.26%) were about dyslipidemia. A significant time-trend was shown in the number of documents (P < 0.001), mostly in 2019. Medicine and pharmacology were subject areas in > 80% of papers. The top country in the global publication number was Iran. The highest cited papers in dyslipidemia, obesity and osteoporosis were original articles from Turkey and Egypt, but in T2DM and MetS the highest cited paper was a review article from Iran. The top sources were “Phytotherapy Research” and “the Journal of Ethnopharmacology”. The top institutes were from Egypt, Iran, and Saudi Arabia and the principal author in the co-authorship network assessment was from Iran. Conclusions: The time-trend growth in producing scholarly papers in the studied disorders is appreciated, but more evidence-based articles are still needed.en
DOIhttps://doi.org/10.5812/jjnpp.102434en
KeywordBibliometricsen
KeywordDiabetes Mellitusen
KeywordHerbal Medicineen
KeywordMetabolic Syndromeen
KeywordMiddle Easten
PublisherBrieflandsen
TitleThe Trend of Scientific Productions on the Use of Herbal Medicines in Metabolic Disorders in the Middle East Countriesen
TypeSystematic Reviewen

Files